Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114676443 | 11467644 | 3 | F | 201005 | 20160912 | 20150908 | 20160916 | EXP | US-ABBVIE-15K-163-1408233-00 | ABBVIE | 55.41 | YR | M | Y | 81.72000 | KG | 20160916 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114676443 | 11467644 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1041343 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 114676443 | 11467644 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1041343 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 114676443 | 11467644 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1041343 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 114676443 | 11467644 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | |||||
| 114676443 | 11467644 | 5 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | D | UNKNOWN | 0 | 1 | DF | TABLET | /wk | |||||
| 114676443 | 11467644 | 6 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | D | UNKNOWN | 0 | 2 | DF | TABLET | ||||||
| 114676443 | 11467644 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 8 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 9 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 10 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 11 | C | L-THYROXINE | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 13 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | /wk | |||||||||||
| 114676443 | 11467644 | 14 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 15 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 16 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 17 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 114676443 | 11467644 | 18 | C | HYDROCODONE | HYDROCODONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114676443 | 11467644 | 1 | Rheumatoid arthritis |
| 114676443 | 11467644 | 4 | Rheumatoid arthritis |
| 114676443 | 11467644 | 5 | Product used for unknown indication |
| 114676443 | 11467644 | 7 | Rheumatoid arthritis |
| 114676443 | 11467644 | 8 | Rheumatoid arthritis |
| 114676443 | 11467644 | 9 | Insomnia |
| 114676443 | 11467644 | 10 | Hypertension |
| 114676443 | 11467644 | 11 | Hypothyroidism |
| 114676443 | 11467644 | 12 | Blood cholesterol increased |
| 114676443 | 11467644 | 13 | Product used for unknown indication |
| 114676443 | 11467644 | 14 | Mineral supplementation |
| 114676443 | 11467644 | 15 | Product used for unknown indication |
| 114676443 | 11467644 | 16 | Product used for unknown indication |
| 114676443 | 11467644 | 17 | Product used for unknown indication |
| 114676443 | 11467644 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114676443 | 11467644 | HO |
| 114676443 | 11467644 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114676443 | 11467644 | Asthenia | |
| 114676443 | 11467644 | Back pain | |
| 114676443 | 11467644 | Balance disorder | |
| 114676443 | 11467644 | Bedridden | |
| 114676443 | 11467644 | Cataract | |
| 114676443 | 11467644 | Device loosening | |
| 114676443 | 11467644 | Dizziness | |
| 114676443 | 11467644 | Hypoaesthesia | |
| 114676443 | 11467644 | Metamorphopsia | |
| 114676443 | 11467644 | Movement disorder | |
| 114676443 | 11467644 | Muscle spasms | |
| 114676443 | 11467644 | Muscular weakness | |
| 114676443 | 11467644 | Nausea | |
| 114676443 | 11467644 | Neck pain | |
| 114676443 | 11467644 | Neoplasm malignant | |
| 114676443 | 11467644 | Nerve compression | |
| 114676443 | 11467644 | Nerve root compression | |
| 114676443 | 11467644 | Neuralgia | |
| 114676443 | 11467644 | Neuropathy peripheral | |
| 114676443 | 11467644 | Postoperative adhesion | |
| 114676443 | 11467644 | Retinal detachment | |
| 114676443 | 11467644 | Retinal vein occlusion | |
| 114676443 | 11467644 | Spinal column stenosis | |
| 114676443 | 11467644 | Spinal cord compression | |
| 114676443 | 11467644 | Spinal operation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114676443 | 11467644 | 1 | 200508 | 0 | ||
| 114676443 | 11467644 | 2 | 2013 | 201604 | 0 | |
| 114676443 | 11467644 | 3 | 201608 | 0 | ||
| 114676443 | 11467644 | 4 | 200508 | 2013 | 0 |